The continued decline of plasma transfusions in Taiwan: An 11-year population-based study
- PMID: 34905221
- DOI: 10.1111/vox.13222
The continued decline of plasma transfusions in Taiwan: An 11-year population-based study
Abstract
Background and objectives: In Taiwan, plasma use per capita ranks among the highest in the world. We aimed to describe the trends in usage after the introduction of new hospital accreditation standards that evaluate compliance with institutional plasma transfusion guidelines.
Materials and methods: We identified hospitalizations receiving plasma between 2007 and 2017 from the national health insurance database. We estimated plasma transfusions per thousand capita. The risk ratio of transfusion rates among hospitalizations in 2017 compared to 2007 was estimated using logistic regression.
Results: The total number of plasma transfusions declined from 964,408 in 2007 to 659,828 in 2017, yielding a rate of 28.00 per thousand capita. The proportion of hospitalizations receiving plasma declined by 38%, from 3.89% (95% confidence interval: 3.86%-3.91%) to 2.62% (2.61%-2.64%). Gastroenterology (16.4%) and general surgery (15.3%) accounted for the largest proportions of plasma usage. Within these two services, liver diseases were the top diagnoses needing plasma use. For hospitalized patients with liver diseases, approximately 40% of plasma units were administered to patients with neither noticeable bleeding nor red blood cells transfusions. Among these patients, almost 50% received plasma with an international normalized ratio trigger of less than 1.50. The use of potential alternative therapies or anticoagulants remained quite low during this period.
Conclusion: Plasma utilization rates during hospitalizations continuously declined over 11 years. However, inappropriate plasma use remained high, while the use of alternative therapies remained low in services such as gastroenterology. To improve the appropriateness of plasma transfusions, patient blood management should be implemented in the near future.
Keywords: hospital accreditation standards; international normalized ratio; liver diseases; national health insurance; plasma.
© 2021 International Society of Blood Transfusion.
Similar articles
-
Impacts of COVID-19 pandemic on the collection and use of blood and blood components in Taiwan.J Formos Med Assoc. 2025 Feb;124(2):151-156. doi: 10.1016/j.jfma.2024.03.017. Epub 2024 Mar 27. J Formos Med Assoc. 2025. PMID: 38548525
-
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018.Blood Adv. 2021 Oct 26;5(20):4179-4184. doi: 10.1182/bloodadvances.2021005361. Blood Adv. 2021. PMID: 34551093 Free PMC article.
-
Coagulation defects do not predict blood product requirements during liver transplantation.Transplantation. 2008 Apr 15;85(7):956-62. doi: 10.1097/TP.0b013e318168fcd4. Transplantation. 2008. PMID: 18408574
-
Exploring Peaks in Hospital Blood Component Utilization: A 10-Year Retrospective Study at a Large Multisite Academic Centre.Transfus Med Rev. 2021 Jan;35(1):37-45. doi: 10.1016/j.tmrv.2020.10.002. Epub 2020 Nov 12. Transfus Med Rev. 2021. PMID: 33341326 Review.
-
Appropriateness of fresh-frozen plasma usage in hospital settings: a meta-analysis of the impact of organizational interventions.Transfusion. 2010 Jan;50(1):139-44. doi: 10.1111/j.1537-2995.2009.02371.x. Epub 2009 Aug 31. Transfusion. 2010. PMID: 19719469
References
REFERENCES
-
- Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, et al. Evidence-based practices guideline for plasma transfusion. Transfusion. 2010;50:1227-39.
-
- AABB website. Available from: http://www.aabb.org/advocacy/regulatorygovernment/bloodcomponents/plasma...
-
- Green L, Bolton-Maggs P, Beattie C, Cardigan R, Kallis Y, Stanworth SJ, et al. British Society of Haematology guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patients groups in the absence of major bleeding. Br J Haematol. 2018;181:54-67.
-
- Tinmouth A. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding. Transfus Apher Sci. 2012;46:293-8.
-
- Luk C, Eckert KM, Barr RM, Chin-Yee IH. Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. CMAJ. 2002;166:1539-40.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources